A double‐blind, placebo‐controlled study of immunotherapy with an alginate‐conjugated extract of Parietaria Judaica in patients with Parietaria hay fever
Abstract
A double‐blind, placebo‐controlled study was conducted to evaluate the efficacy and safety of immunotherapy (IT) with a partially purified alginate‐conjugated extract of Parietaria judaica (Conjuvac®Parietaria, Dome/Hollister‐Stier) in patients suffering from rhinoconjunctivitis caused by Parietaria pollen. Eighteen patients (10 women, 8 men, mean age 35 years) received active treatment and 17 (10 women, 7 men, mean age 42.5 years) received placebo. Actively treated patients had significantly lower nasal symptom/medication scores (running nose P= 0.0087 and sneezing P= 0.048) during the Parietaria pollen season. Significant decreases in specific skin (P > 0.01), nasal (P > 0.05), and conjunctival (P > 0.01) reactivity to the Parietaria extract and significant increases of specific IgG (P > 0.001), IgGI (P > 0.001), and IgG4 (P > 0.001) in actively treated patients, but not in placebo, were found. IT was well tolerated, the active extract inducing five mild systemic reactions (four rhinitis and one urticaria) and placebo two (rhinitis). A significant correlation was found between low skin reactivity and high specific IgG (P= 0.0002) and IgG4 (P= 0.036). These findings indicate that IT with a partially purified P. judaica extract is an effective and safe treatment for Parietaria pollen allergy. The correlation between low immediate skin reactivity and high specific IgG and IgG4 suggests that, at least in the studied cutaneous model, these antibodies may exert a blocking effect.Keywords
This publication has 22 references indexed in Scilit:
- Clinical and immunological effects of immunotherapy with alum‐absorbed grass allergoid in grass‐pollen‐induced hay feverAllergy, 1992
- A double‐blind study of hyposensitization with an alginate conjugated extract of D. pteronyssinus (Conjuvac®) in patients with perennial rhinitisAllergy, 1989
- Suppression of the late cutaneous response by immunotherapyJournal of Allergy and Clinical Immunology, 1989
- Sensitivity to Parietaria pollen in the Southampton area as determined by skin‐prick and RAST testsClinical & Experimental Allergy, 1988
- Immunochemical Characterization of Antigens of Parietaria judaica PollenInternational Archives of Allergy and Immunology, 1985
- IgG Subclass Antibody Response in Grass Pollen‐Allergic Patients Undergoing Specific ImmunotherapyAllergy, 1984
- Grass pollen immunotherapy: A single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitisJournal of Allergy and Clinical Immunology, 1984
- The effect of ascorbic acid on cutaneous and nasal response to histamine and allergenJournal of Allergy and Clinical Immunology, 1982
- A double-blind, placebo-controlled trial of polymerized whole ragweed for immunotherapy of ragweed allergyJournal of Allergy and Clinical Immunology, 1982
- Immunotherapy in Hay Fever with Two Major Allergens 19, 25 and Partially Purified Extract of Timothy Grass PollenAllergy, 1980